The RCVS is advising all practices that it is not currently carrying out a data-gathering exercise and that phone calls prompting the return of a survey, and requesting mobile phone numbers, are not being made on behalf of the College.
The warning comes after several practices have called the College to query 'feedback forms' - supposedly issued in relation to the Practice Standards Scheme or the payment of members' retention fees.
The practices were asked to return forms which they had not received, and also to provide mobile phone numbers, by someone who claimed to work for the 'statutory regulator' or 'the RCVS'. Contact phone numbers left by the caller were either RCVS fax numbers or numbers which looked like RCVS direct dial numbers, but were not.
Lizzie Lockett, Head of Communications, said: "This looks like an exercise to gain mobile phone numbers which is being carried out in the College's name. We are currently investigating who might be making these calls. In the meantime, if a practice receives such a call, it would be helpful if they could take down a name and contact number and let us know."
Ring 020 7202 0725 or email l.lockett@rcvs.org.uk to report any suspicious activity.
Pfizer Animal Health, maker of the equine wormers Equest and Equest Pramox, has unveiled www.wormingyourhorse.info, a new website which aims to make it easier for horse owners to understand and follow the most up-to-date principles of sustainable worm control.
Based on the company's Manage, Test, Plan, Dose campaign, Pfizer says the new website is designed to take the confusion out of equine worm control with clear, logical and easy-to-understand guidance and advice.
The four main sections use diagrams and text to explain how and why it's important to manage the worm challenge on the pasture; the role of faecal worm egg counts (FWECs); how history and management play a part in planning the best worm control programme and how to choose and use the right wormer at the right time of year.
There's an interactive and educational parasite page that shows the parasites that can affect the health of your horse. There are click through buttons on parts of the horse's anatomy revealing details about the appearance of each particular parasite, their lifecycle and the symptoms they can cause. In addition there's a section on frequently asked questions which provides no-nonsense answers to some of the most commonly asked questions about worm control.
Paul Blanc, Pfizer's equine brand manager said: "In developing our new website we have listened carefully to what horse owners really want and need to know. The result is a source of plain-speaking, unbiased facts and advice, providing horse owners with the most current thinking on sustainable worm control in a format they can really identify with."
The International Society of FelineMedicine (ISFM) and the American Association of Feline Practitioners (AAFP) have produced a set of guidelines to help all members of the veterinary team provide high quality feline nursing care that promotes wellness and successful recovery from illness or surgery while addressing the patient's physical and emotional wellbeing.
The guidelines have been published in the May 2012 issue of the Journal of Feline Medicine and Surgery (JFMS, 14; 337-349) and are available to all ISFM members in the usual way. In addition, the guidelines are freely available for anyone to download from JFMS online at the following link: http://jfm.sagepub.com/content/14/5/337.
The AAFP and ISFM Feline-Friendly Nursing Care Guidelines encourage veterinary team members to look at feline nursing care in ways they previously may not have considered and provide numerous practical tips gleaned from the many years of combined clinical experience of its eight authors.
Claire Bessant, Chief Executive of the ISFM said: 'As part of our mission to improve feline health and wellbeing worldwide, we will be making all guidelines published in JFMS free to download for all'.
For more information, visit www.isfm.net.
The British Veterinary Nursing Association and the Society of Practising Veterinary Surgeons have launched a waiting room poster to help practices raise awareness of the status of their VNs and promote the welfare benefits that VNs can help provide.
Rolled copies of the A2 posters are available in a tube for £2.50 (to cover postage). Folded copies are free or you may download the poster here.
Contact the BVNA office on 01279 408644 to request a copy.
Woodley Equipment has launched ImmunoComb diganostic test kits for FIP, canine Leptospira and Ehrlichia
Woodley says the kits are easy to use and provide results within 20 minutes. No specialist laboratory equipment is required as the kits are self-contained with all the necessary reagents. The diagnostic kits determine the animal's antibody titre levels, in the case of the canine Ehrlichia as early as 7 days after infection, giving veterinary surgeons the opportunity to act more quickly in developing a prevention/treatment program.
Tests can be performed singly or up to 12 simultaneously.
For more information about ImmunoComb Diagnostic kits email sales@woodleyequipment.com or call: +44 (0) 1204 669033 Option 1. Alternatively visit http://www.woodleyequipment.com/
A record number of candidates stood in the RCVS Council election this year, and the results were much closer than usual.
Two candidates entirely new to the Council have been elected, one of whom - Amanda Boag - received the highest number of votes. The other - Chris Barker - also did well, coming in third place overall.
Three existing RCVS Council Members have been re-elected for a further four years, and Stephen May, who was formerly an appointed Council Member from the Royal Veterinary College, was also voted onto Council for the first time.
Of the three candidates standing for election to VN Council, one existing Member - Kathy Kissick - has been returned, and one new member - Elizabeth Figg - has been elected.
All successful candidates will take up or resume their seats at RCVS Day on 6 July 2012.
Turnouts for both elections remained low, with just 3,625 veterinary surgeons (15.1%) and 743 veterinary nurses (7.5%) choosing to exercise their right to vote.
By comparison, in 2011 voting figures were 3,887 (15.9%) and 723 (7.6%), respectively.
Veterinary surgeons' and veterinary nurses' use of online and text voting, rather than postal voting, increased again this year from 25% to 30.6%, and 12.9% to 20%, respectively.
Kruuse has launched Krutex Polyisoprene Surgical Gloves, which are both powder and latex-free to minimise the risk of glove-related allergy to latex protein.
The gloves are made from synthetic polyisoprene, which has a molecular structure similar to natural rubber latex. This, says the company, means the gloves have a fit, sensitivity and comfort equal to natural rubber latex. The company says they are also designed to provide increased fingertip sensitivity.
Andrew Groom Managing Director, Kruuse UK Ltd said: "After feedback from our customers showed an increasing concern regarding latex allergies amongst clinicians, we were encouraged to develop this addition to our well established range of gloves."
Krutech latex free gloves join the existing Krutech range which includes; Vet Gel surgeons' gloves, Krutech latex surgical gloves, Krutech latex, vinyl and nitrile examination gloves and the widely used arm length gloves range. The new range is supplied in boxes of 25 sterile, single packed pairs and are available in half sizes from 6.0 to 9.0.
The University of Bristol and Companion Care have launched The Great Pet Travel Survey 2012 to assess disease risks in the UK following the simplification of Pet Travel Scheme rules.
Companion Care and The University of Bristol say that there is a great deal of concern about what risks changes in the Pet Travel Scheme Rules pose to the health of the human and dog population in the UK.
Robert White-Adams MRCVS from Companion Care said: "At present there is minimal data available to answer this question as current data logging is minimal and paperwork checking at ports can be variable. We therefore have little idea of how many UK-resident dogs travel abroad, where they visit, how long they stay and what they are doing whilst abroad.
The survey will collect and analyse information about the travel patterns of UK resident dogs, in and around mainland Europe, over the last decade.
Robert added: "The data to be collated by the survey will fill the data void and enable us to provide a quantitative assessment of the disease risk, as well as gaining an understanding of owner awareness of risks face by dogs travelling in Europe.
Owners of dogs with Pet Passports are being encouraged to fill in the short questionnaire, which is available now at http://www.greatpetsurvey.co.uk/. All completed questionnaires will be entered into a prize draw to win £100 of Pets at Home vouchers!
The questionnaire will be live online until 30th June 2012 and all data will be analysed by the University of Bristol.
Dr Morgan said: "Without this information we have only a vague idea of the risks that the loss of border controls may pose. The answer could be that there is little additional risk or it could be that the UK dog (and human) population could face some severe disease threats. As it stands now, we just don't know enough to make an informed judgement."
Elanco Companion Animal Health, maker of Comfortis chewable tablets for dogs, has launched a range of support materials to help educate pet owners on flea infestation and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
The Range of Comfortis materials features point of sale equipment including free-standing zig-zag display units, window hanging displays, stacking cubes, freestanding easels and leaflet holders as well as client leaflets, waiting room display kits, posters and 20% discount letterheads and postcards for mail-outs. An animation (shown below) is also now available in various formats for veterinary practices to use on their waiting room monitors or websites. The animation, which aims to educate dog owners on flea infestations and complications, covers common risk factors for flea infestations, flea facts including the lifecycle of the flea and encourages pet owners to ask for further information on oral flea control options.
Matthew Rowe, senior product manager at Elanco Companion Animal Health said: "With many pet owners seeking their flea control solutions from other sources, such as the increasingly competitive pet superstores, veterinary businesses need to provide unique preventative healthcare services to their clients to help bond them to the practice and ensure that they return again and again. The new Comfortis support materials will help raise client awareness of the benefits of veterinary prescribed flea treatments and thereby help differentiate veterinary practice flea control solutions from those available in country stores, pet shops, supermarkets and pharmacies."
For further information on Comfortis, or the range of support materials, contact your Elanco Companion Animal Health key account manager or email elancocah.uk@lilly.com.
Royal Canin has announced the launch of a summer campaign to help small animal practices develop their relationships with cat-owning clients.
'Summer of the Cat' runs throughout July, August and September. As part of the campaign, cat owners are being invited to share adventures their cat has over the summer with their vet practice, for the chance to win a year's supply of Royal Canin cat food.
Entry forms, which contain spaces for photos and drawings, will be distributed to practices along with other promotional materials such as balloons, posters, bunting, tent cards and wobblers.
The competition - which also gives entrants the chance to win large A3 posters of their 'Summer of the Cat' storyboards - is being supported by a promotional offer to 'feed your cat free for a week' from July to September.
Veterinary Marketing Manager, Lindsay Calcraft, said: "Customers will be able to buy any 1.5 - 2kg bag of feline Veterinary Care Nutrition from their vet and get a 400g bag free. Those cat owners taking up the offer will also receive a money off voucher (£3/€4) for their next purchase to encourage loyalty and increased footfall in the participating vet practices."
For more information, visit www.royalcanin.co.uk or contact your Veterinary Business Manager.
Boehringer Ingelheim Vetmedica has extended its Metacam 0.5 mg/ml Oral Suspension for Cats range with the launch of a 30ml bottle size, which the company says will last the average 5 kg cat for two months.
According to Boehringer, the new 30ml bottle will offer owners a cost saving compared to purchasing two 15 ml bottles. In addition, it will provide greater prescription options for veterinary practices currently stocking 3ml and 15 ml bottles,,
Andrew Francis, Metacam brand manager said: "The new 30ml bottle of Metacam Oral Suspension for Cats will provide both veterinary practices and their clients with a product that is great for the long-term treatment of chronic pain in cats in one convenient pack."
For further information on Metacam, contact your local Boehringer Ingelheim Vetmedica territory manager or telephone 01344 746959.
Petplan has launched a new system through which veterinary staff at Appointed Representative (AR) practices can activate 4 weeks Immediate Veterinary Cover (IVC) for clients' puppies, kittens and rabbits at www.petplanvet.co.uk.
Petplan says the new system will greatly improve its service to the veterinary industry, enabling same day information transfer, reducing the amount of paperwork and admin for veterinary staff as well as ruling out the chances of paperwork getting lost or delayed in the post.
Simon Masding, Petplan Head of Sales and Partnerships said: "Petplan has the most established cover note scheme in the market and due to the strength of our brand and the products we offer is able to generate more insured clients for practices than any other provider. Our team of Account Executives visit practices across the UK on a daily basis which means we understand the pressures of day-to-day practice life. Our new online IVC service is just one of the innovative ways we try to make things easier for veterinary staff so they can focus on looking after clients and their pets."
For more information about becoming a Petplan AR practice, and Immediate Veterinary Cover, call Petplan's Vetline on 0800 316 8800.
Any practices that activate IVC online at petplanvet.co.uk before 31st July 2012 will be entered into a prize draw to win an iPad.
he leaflet has been produced following changes in legislation concerning maternity, paternity and adoption, and covers issues such as:
The leaflet includes timelines for quick reference together with health and safety advice, including a template risk assessment form.
Professor Bill Reilly, BVA past president, chaired the members services sub group which developed the document. He said: "This Guidance tells everyone in the practice team what they need to know about pregnancy in the workplace.
"Developed with the help of human resources and legal experts this Guidance answers common questions, gives a great overview of what should happen when, as well as who has which rights and responsibilities.
"It is specifically tailored to the veterinary environment so vets, vet nurses and practice managers should all find the clear advice useful."
BVA members can download the guide from www.bva.co.uk/guides.
Almost 90% of the British public think that microchipping dogs should be compulsory, according to a new survey carried out by Petlog, the lost and found pet database.
A public consultation into compulsory microchipping, which proposes that microchips are used to help tackle the issue of dangerous dogs, closes today. Interestingly however, the survey showed that the main reason for compulsory microchipping should be to help speed up the return of a lost pet, although 38% of those who are in favour of compulsory microchipping also thought it would help to tackle dangerous dogs.
Celia Walsom, Petlog Executive said: "The results from this survey were very promising and showed that there is huge support out there for compulsory microchipping. I hope that the public consultation demonstrates the true extent of public support and that Defra will seriously take this on board.
"Unfortunately, press coverage surrounding compulsory microchipping has been focusing on the issue of dangerous dogs and has ignored the main objective of a microchip which is reunification.
The Microchipping Alliance which comprises animal welfare charities, veterinary organisations, assistance dog charities, dog membership organisations and others who are impacted by dog issues, released a briefing at the end of last year that looked into the economic consequences of compulsory microchipping. The briefing states that if compulsory microchipping was to be introduced to all dogs there is a potential saving of over £20 million from reduced kennelling and other costs associated with stray dogs.
Celia continued: "The reasons for compulsory microchipping are strong. We at Petlog along with the Microchip Alliance and a number of other organisations want to see microchipping made compulsory to help dog welfare and reduce the number of dogs needlessly rehomed or put to sleep because they couldn't be reunited with their owner."
Petlog conducted the survey using visitors to the London Pet Show to find out public feeling regarding compulsory microchipping.
This month is National Microchipping Month, an initiative run by Petlog to promote the benefits of microchipping to pet owners and also encourage people to make sure that their contact details are up to date.
If you would like to take part in Petlog's microchipping survey, you can still do so, here: https://www.surveymonkey.com/s/Petlogmicrochipping.
For more information, visit www.nationalmicrochippingmonth.org.uk.
Norbrook Laboratories Ltd has launched Mycinor tablets (clindamycin), an antibiotic for treating soft tissue infections in dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Clindamycin is one of the leading prescription medicines used to treat soft tissue infections and offers very effective treatment particularly for dental and oral infections.
"Mycinor can be used to treat infected mouth cavities and oral infections and to provide antimicrobial cover prior to dental procedures such as tooth removal, scale & polish etc. Beyond dental expertise, Mycinor can also be used to treat soft tissue infections, skin infections in the form of superficial pyoderma and osteomyelitis bone infections. Mycinor is a fast acting antibiotic, rapidly absorbed into the body with effective levels within 30 minutes of administration."
Mycinor is available as 25mg, 75mg and 150mg in packs of 100tablets, and as a 300mg tablet in a pack of 150 tablets. Rebekah added: "Mycinor is a very effective and safe antibiotic and is ideal for long and short term treatments. It can be dosed once daily or at twice daily intervals if preferred."
For more information, visit www.norbrook.com
Following issues with the implementation and associated costs of the Royal College of Veterinary Surgeons' database (iMIS), independent IT specialists TFX Consulting Ltd have reported on both the implementation project and the long-term suitability of the database for the College's needs.
The TFX iMIS Report highlights inadequacies in the procurement process for the IT system, especially with regard to the drafting of the original brief. The Report suggests that this led to differing expectations from the College and ASI, the company licensing and assisting with the implementation of the software, in terms of the detail and complexity of the project.
Although TFX says it believes the iMIS system to be suitable for the finance functionality required, it is critical of its ability to support some other RCVS data structures, and considers it is a poor fit for the complex registration and education functions of the College. The Report writers note that the RCVS continues to fulfil its statutory duties in terms of fee collection and the maintenance of registration records.
The key recommendations of the Report are that the RCVS continues to work with the iMIS database in the immediate future, particularly with regard to core functions, but that a new partner is sought for ongoing support of the system. Thereafter, the Report recommends that a plan is put in place to migrate away from the system over a period of two to three years, as part of a natural upgrade path for RCVS IT systems.
As part of this programme, TFX recommends that a detailed analysis exercise is required, with the objective of more completely defining the College's complex requirements.
This is the second of two reports prepared by TFX; the first reviewed the College's technology more generally. The Technology Report provided valuable advice in areas of network security, staged replacement of legacy hardware and a coherent software and licensing programme, with associated staff training.
The TFX iMIS Report can be downloaded from http://www.rcvs.org.uk/TFX
The TFX Technology Report will not be published, as it concerns issues relating to security of the College's IT infrastructure.
RCVS President Jerry Davies said: "We are grateful to TFX Consulting, and Ben Murray in particular, for the depth and clarity of both of their reports. It has been very useful to have independent scrutiny of the iMIS project and our IT systems as a whole.
"Lessons can be - and have been - learned. For example, new project management protocols have been introduced by the College, and the instigation of an Audit and Risk Committee has been agreed".
Council accepted the findings of the Report at its recent meeting, and the new Chief Executive and Secretary, Nick Stace, will consider how the recommendations are best implemented, when he takes up his post in September 2012.
ProteqFlu, the live attenuated canarypox equine influenza (EI) vaccine, has had its shelf life extended from 27 to 36 months.
Merial says the increased shelf life is the result of ongoing investment in vaccine research & development, and that the new data underpins the stability of modified live vaccine technology.
Merial highlights that ProteqFlu is the only equine flu vaccine in Europe to include the updated American clade 1 Ohio/03 strain in accordance with the OIE recommendations (2004).
Ceva Animal Health has launched a new travel size 20ml bottle of Feliway Spray to help cat owners keep their pet comfortable whilst travelling this summer.
To promote the launch Ceva is giving away thousands of prizes to Feliway customers, offering them the chance to win a top prize of a spa day at Champneys, cat carriers, soft toys and travel stickers, whilst stocks last. To take part, customers need to enter their unique pack code via the Feliway Facebook page to toss an online coin to see what they have won.
In addition, veterinary surgeries that purchase a 12 pack of the 20ml spray will get a second 12 pack free.
Julia Wood, product manager at Ceva said: "Transporting cats even short distances, for necessary trips to the vet, cattery or to a local show, can easily become a nightmare for both the cat and the owner. We've introduced the new travel size spray to make it even more convenient for cat owners when they are on the move and we hope the extra competition incentive will drive sales for veterinary clinics."
Virbac Animal Health has announced that its medical castration implant Suprelorin 9.4mg has received a marketing authorisation for use in ferrets.
The neutering of male ferrets (hobs) is recommended to suppress fertility, decrease odour and reduce territorial aggressive behaviour and urinary marking¹. According to Virbac, Suprelorin offers temporary sterilisation but without the need for surgery, and its use prevents the high Luteinizing hormone (LH)/Follicle-stimulating hormone (FSH) levels which occur following surgery and which can play a role in the development of hyperadrenocorticism².
Suprelorin is a slow-release implant containing the gonadotropin-releasing hormone (GnRH) agonist deslorelin. Once injected under the skin of healthy, sexually mature and entire ferrets, the continuous low release of deslorelin from the implant causes an interruption of the HPA circuit, leading to a reduction in LH/ FSH levels and therefore testosterone production. This results in a reduction of libido, spermatogenesis and testicle size.
The implant lasts for up to four years, at which stage the ferret can be re-implanted to maintain the effect.
Chris Geddes MRCVS, Virbac Product Manager, said: "For owners looking for a surgery-free route to the castration of male ferrets and the problems it can cause, Suprelorin provides a simple and effective alternative."
Suprelorin 4.7mg has been available for use in dogs since 2008. Suprelorin 9.4mg was launched in 2011.
For further information, please contact your Territory Manager or call Head Office on 01359 243243.
References:
Virbac Animal Health has launched an extra small version of its VeggieDent dental chews for dogs weighing less than 5kg.
Research commissioned by the company shows that 9% of all dogs in the UK weigh less than 5kg1 and that periodontal disease is over-represented in this group2.
According to the Kennel Club, celebrity culture is boosting the popularity of small breeds. Apparently there was a 25% increase in Kennel Club registrations of Chihuahuas in 2011, following publicity about Paris Hilton and her Chihuahua. Virbac says numbers of other small miniature breeds such as pugs are also growing rapidly.
Virbac says VeggieDent chews are designed to work with the animal's chewing action, 100% vegetable, highly palatable and feature a special design to increase chewing time. A recent study3 showed that a daily XS VeggieDent reduced halitosis as well as significantly reducing gingivitis, plaque, and tartar accumulation.
Chris Geddes MRCVS, Product Manager at Virbac said: "With growing numbers of very small dogs in the UK, we wanted to produce a chew which was exactly the right size for them.
VeggieDent Chews are already popular among dog owners because they are a nutritious and palatable plaque control aid, minimising tartar build up and improving breath odour. With the launch of the extra small size, we now offer the perfect chew for every size of dog."
For further information, contact your Territory Manager or call Head Office on 01359 243243.
Royal Canin has launched its second 'Weigh-in Club' competition to help cats and dogs lose weight safely.
Royal Canin says the competition is designed to reward veterinary nurses who work with their clients to tackle pet obesity effectively. Last year, it had over 170 registrations.
The competition is open to vet nurses whose clients' pets have undergone a supervised weight loss programme (being fed exclusively on Royal Canin diets) and have met their target weights. The overall winning nurse will receive £500 worth of high street shopping vouchers as well as £1,000 of equipment vouchers for their practice. Every nurse that submits a qualifying entry will receive a free silicone watch and two entries will win them a Royal Canin fleece.
Royal Canin's Gudi Stuttard said: "With canine and feline obesity on the increase, veterinary nurses have an important role to play in educating pet owners and supporting the weight loss process. That's why we're looking for the very best examples so that we can celebrate the success of nurses, practices and clients and demonstrate to other owners how important and achievable it is to help pets reach a healthy weight."
Participating practices will be sent competition materials for display, to encourage their weight-loss clients to take part in the competition. Nurses will also have the chance to track their entrants' progress on Royal Canin's new interactive website, where you can upload 'before and after' photos and compare weight loss with other competitors.
As an added incentive to pet owners, the overall winning client will receive free Royal Canin pet food for a year and £500 worth of high street shopping vouchers. The top 11 runners up will appear, alongside the winner, in an exclusive Royal Canin calendar and every owner that enters will receive a 'Company of Animals' Activity Pyramid to help them keep their pets in great shape.
Vet nurses can register online by visiting www.weighinclub.royalcanin.co.uk. This year's competition closing date is 30 September 2012, with the winner and runners up announced at the end of November.
The Kennel Club Charitable Trust has announced that nominations are now open for its new Veterinary Awards for veterinary surgeons, scientists and veterinary students that are carrying out innovative research that will help to improve dog health.
According to the charity, the Awards will identify and encourage visionary thinking, ambition and life-changing accomplishments and those who receive the awards will be passionate about making a difference for dogs. Each award provides a large funding programme to the recipient, which rewards them for their dedication and innovation in the field of canine health and welfare and invests in helping them to continue making a difference for dogs. The awards will be:
The awards will be judged by representatives from the veterinary profession and the world of scientific research, including experts in the nominees' selected fields. Dr. Alan Kelley, Dean Emeritus of The University of Pennsylvania School of Veterinary Medicine, will chair the distinguished committee selecting the International Prize Winner.
Vernon Hill, Founder and President of Metro Bank and Shirley Hill, whose Foundation underwrites the Awards, said: "Metro Bank is a visionary, innovative bank, and we support the same spirit in these prestigious awards. Dogs Rule at Metro Bank, and we welcome them in with fresh water bowls, treats and Metro Scarves 361 days a year. We look forward to our gift making a difference and supporting the future leaders in veterinary science."
Rosemary Smart, Kennel Club Chief Executive, said: "We are extremely pleased to be working with Vernon and Shirley in this exciting Awards scheme, which will reward and support those people whose work is making a difference to dogs' lives."
To nominate somebody for these awards contact: cas.oakes@thekennelclub.org.uk or write to:
Cas OakesThe Kennel Club Charitable Trust1-5 Clarges StreetPiccadillyLondonW1J 8AB
Nominations for the Student Inspiration should come from the Deans/Faculty Directors of British Veterinary Schools.
For further information and to find out how to enter visit: www.thekennelclub.org.uk/charitabletrust
The BSAVA reports that its inaugural Rehabilitation and Physiotherapy VN Merit Award is already fully subscribed, with places on other programmes proving hugely popular.
The association says it created the VN Merit Awards having identified a demand amongst nurses for focussed and cost-effective CPD which could fit into busy lives. Academic Director Dr Frances Barr said: "Veterinary nurses have an increasing desire to stretch their skills and expand their contribution to the clinical team, and the new awards will provide that opportunity. They deserve the support of the whole profession.
"VNs taking part in these programmes can expect to strengthen their theoretical knowledge and to learn important practical skills in an area of particular interest to them. At the end they will be taking greater confidence and new skills back into the practice which they can share with the wider practice team."
Despite being a brand new course, BSAVA says that there there is clearly faith that it can continue to deliver relevant, challenging CPD for nurses. The first two Merit Awards will run in autumn 2012. All the places on Rehabilitation and Physiotherapy have been booked, but interested individuals can join a waiting list for the next course. Anaesthesia and analgesia has also proved popular, with just a few places left, at the time of writing. Further merit awards in wildlife nursing and in surgical nursing are planned for 2013.
For further information, email courses@bsava.com or visit www.bsava.com/cpd.
The BVA has welcomed an update report on dog breeding issues by the Associate Parliamentary Group for Animal Welfare (APGAW).
Working with a small group of stakeholders including the British Veterinary Association, Dogs Trust, Kennel Club and RSPCA, this report looks at what has been done since the first APGAW report in late 2009 and the airing of Pedigree Dogs Exposed (2008) and Pedigree Dogs Exposed: Three Years On (2012).
BVA Past President Harvey Locke said: "The BVA fully endorses the recommendations and practical solutions offered by this timely report."
Mr Locke drew attention to a number of points in the report's action plan including:
Mr Locke added: "I am pleased that the APGAW report recognises the vital role that education plays in tackling irresponsible dog ownership and would very much like to see the inclusion of animal welfare as part of the core curriculum.
"I am also delighted that the group recognises the value of a puppy contract. The BVA Animal Welfare Foundation and RSPCA have recently launched a puppy contract and puppy information pack (PIP) which arms buyers with the knowledge to give themselves the best chance of getting a fit, healthy and happy, well socialised pet to join their household. The contract and PIP have also been designed to help good breeders demonstrate the care and attention they have devoted to their puppies' breeding and upbringing.
"Much work has already been undertaken to improve dog breeding but there is much more to be done and the momentum must not be lost. I am most grateful to Neil Parish MP, chairman of APGAW, for his commitment to producing this report. It is an excellent means of keeping the issue high on the agenda by encouraging wider dialogue and debate within Parliament and in the EU."
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
References